2018 Advances in Cancer Immunotherapy - Dallas Recorded Webinar 1

Program Summary
From the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer Immunotherapy™ (ACI) webinar recording for the 2018 Dallas event is provided here. The purpose of this webinar series is to help healthcare providers stay informed about cancer immunotherapy. 

 

Webinar Faculty

Rolf Brekken, PhD - UT Southwestern Medical Center

Saad Khan, MD - UT Southwestern Medical Center

 

Webinar Date

March 19, 2018

 

View Recorded Webinar

 

 Click here to access the recorded webinar.

2018 Advances in Cancer Immunotherapy - Dallas Recorded Webinar 1

Program Summary
From the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer Immunotherapy™ (ACI) webinar recording for the 2018 Dallas event is provided here. 

 

Join Rolf Brekken, PhD, and Saad Khan, MD, from UT Southwestern Medical Center, as they take a deeper dive into irAE mechanism and management by dissecting a case study.

 

Topics addressed in this webinar include:

  1. Case study on mRCC treated with anti-PD-L1 Ab therapy
  2. irAE management
  3. Mechanism behind anti-PD-L1 and immune checkpoint adverse events
  4. Biomarkers
  5. Tumor mutation burden 
Speaker Information
Rolf Brekken, PhD  [ view bio ]
Saad Khan, MD  [ view bio ]
Individual topic purchase: Selected